Quote by
Symbol: Exchange:
Subscriber Login Customer Service 1-800-804-8846
   Buy-Sell Research Reports
Select a specific report
Symbol
or
Name
View a number of reports
View reports alphabetically by Symbol
First letter

FREE REPORT
"10 Undervalued Stocks to Buy Now"

Try Buy-Sell Research Reports for the low monthly rate of only $9.27 per month and we will send you -- FREE -- our special report on the "10 Undervalued Stocks to Buy Now". PLUS you'll also get regular stock alerts with our "Buy-Sell Hotline" e-mail...at no extra charge. To learn more about this special no-risk offer CLICK HERE.

How to read Buy-Sell Research Reports

     Buy-Sell Research Reports is a powerful research tool which gives you vital information on over 2,000 stocks. Plus in each report you get the consensus buy-sell recommendations of professional analysts across Canada and the opinion of our own Investment Planning Committee.

     Buy-Sell Research Reports may be purchased individually for $10 each. Subscribers have unlimited access to all reports. CLICK HERE for a special subscription offer.

     All reports are in PDF format. Adobe Acrobat is required to view them -- download it here for free. Click here to check if your PDF viewer is working properly.

     The quick reference guide below gives you the key to all the facts, figures and comparative data in our reports — and also tells you how professional analysts use this data to size up the prospects of the stocks they’re following. Remember, the figures you get in Buy-Sell Research Reports are always current and up-to-the-minute.

3-year chart

(A) Weekly share price range: each vertical line indicates the extent of the share price range for that week.

(B) 10-week moving average price line: this line is an average of the closing prices for the past 10 weeks.

(C) 40-week moving average price line: this line is an average of the closing prices for the past 40 weeks.

(D) Weekly share volume: each vertical bar indicates the number of shares traded that week.

 

Five-year analysis for every stock

     In each Buy-Sell Research Report, our ‘Marpep Multi-year performance analysis’ gives you full and detailed comparisons of a company’s operations for the past five years. This includes yearly breakdowns of income statements, performance and profitability ratios, and balance sheets.

     You also get “per-share” ratings of all vital performance figures — earnings, comparative sales, cash flow, operations and dividends. Plus you get all the other key figures and ratios that define a company’s performance, including price range, dividend yield, price/earnings and debt-to-equity ratios and much more.

Key ratios we use to assess current and potential profitability

EBITDA as a % of revenue: EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) divided by revenues. This ratio, commonly known as the EBITDA operating margin, indicates management’s ability to minimize costs and maximize profits.

Return on assets: Net income divided by total assets. This indicates how much the company earns for each dollar of invested assets.

Revenues as a % of total assets: Revenues divided by the company’s total assets. This indicator gives analysts a precise measurement of management’s ability to generate revenues per dollar of capital invested.

Revenues as a % of total equity: Net income divided by total equity. This shows management's ability to generate revenues per dollar of capital invested.

Return on common equity: Net income divided by shareholders' equity. This represents the amount the shareholder would make per dollar invested.

 

Our quick, easy-to-read summary

(E) Our fundamental recommendation: Unique to Buy-Sell Research Reports, this recommendation is based on key criteria set by the Investment Planning Committee. They measure six key ratios that indicate the underlying strength of a company. Constantly updated, these ratios give you an up-to-the-minute “buy”, “sell” or “hold” recommendation based on positive vs. negative results.

(F) Consensus recommendations: This shows you at a glance the consensus “buy”, “sell” and “hold” advice of all the analysts who contribute to our ongoing survey of stocks.

(G) Analyst coverage: You see the “buy-sell” breakdown among the analysts who have contributed to our survey. We simplify the often complicated terms analysts use to define their recommendations into five specific, easy-to-follow categories.

(H) EPS estimates: This is the consensus figure of the earnings-per-share estimates and 12-month target prices from the analysts who contribute to our ongoing survey of stocks.

(I) MPL’s sector outlook: You get the Investment Planning Committee’s current assessment and long-range forecast for the industry of each stock covered in Buy-Sell Research Reports.

(J) Consensus advice: This is the prevailing consensus of “buy-sell-hold” advice among all the analysts who contribute to our ongoing survey of stocks.

(K) Marpep Quality Ratings: Our exclusive ratings assess investment quality and risk. Stocks with assets over $1.5 billion are Very Conservative; $750 million to $1.5 billion Conservative; $150 million to $750 million Average; $75 million to $150 million Higher Risk; under $75 million Speculative.

(L) Risk Factor: Our unique rating for risk uses dividends as a measuring stick.

(N) Standard Ratios: These ratios provide insight into a stock's operating performance, earnings quality, and financial safety. Keep in mind that stock analysis uses several ratios and their significance may vary between different types of companies.

 

Key ratio charts and valuable comparative analysis

  Buy-Sell Research Reports provides 10 key charts that reveal very specific information you can use to judge a stock’s potential for growth.

(O) EPS Chart traces earnings per share, the most important tool analysts use to measure the fundamental strength of a stock.

(P) P/E Chart provides a road map of future growth: the higher the price/earnings ratio, the less room a stock has for growth.

(Q) Total Assets Chart is the surest gauge of a company’s investment quality and ability to withstand risk through good markets and bad.

(R) Total Revenue Chart reflects a company’s ongoing progress — a dip in revenues can be the first real sign of danger.

(S) Price to Book Value Chart measures shareholders’ true equity in a company: a stock trading below book value is undervalued.

(T) Price to Cash Flow Chart is a key measure of growth — the higher the cash flow in relation to the share price, the more growth you can expect.

(V) Short Positions Chart will tip you off to heavy short selling, which can stabilize the share price and even generate upward momentum.

(W) Price to Revenue Chart is a yardstick analysts use to judge whether a stock is overvalued or undervalued, based on sales over the past 12 months.

(X) Dividend Yield gives you a very clear picture of which stocks generate the highest after-tax returns for their shareholders.

     Buy-Sell Research Reports also gives you one more valuable analytical tool:

(Y) Comparative Financial Analysis lets you see how each company covered compares with the four companies in the same industry closest to it in total revenue. (Z) The chart demonstrates how the five firms’ share prices have performed relative to each other over three years, and the table below carries key facts, figures and ratios for all five companies.

 

Special introductory offer and FREE bonus report

     So you can see for yourself just how profitable adviceforinvestors.com Buy-Sell Research Reports can be, we've arranged a special introductory "no-risk trial" for you.

Try Buy-Sell Research Reports on a no-risk trial basis at the low introductory rate of only $9.27 per month. The regular monthly rate is $23.25. You save over 60%! PLUS you get our valuable report "10 Undervalued Stocks to Buy Now"...ABSOLUTELY FREE!

      BEST OF ALL...when you accept our generous offer of a low-priced introductory trial to Buy-Sell Research Reports, you also get our unique "Pay-As-You-Go" Guarantee. You pay only for the service you use. You may cancel anytime for any reason - and we will immediately stop billing you. You've absolutely no risk!

      Please try Buy-Sell Research Reports today. It could be the most important — and profitable — decision you make this week.

     CLICK HERE to take advantage of our special introductory offer right now. You may also phone toll-free at 1-800-430-1897.

 
 

 

Please send comments or suggestions to feedback@mplcomm.com

© 1996 - 2010 MPL Communications Inc.

Legal Notices   Privacy Policy